insights_auto
Why is MVIR down 7.12%?
Dive Deeperchevron_right
MVIR:STO
Medivir AB
SEKÂ 1.04
arrow_downward
-7.12%(-0.080) 1D
Nov 20, 5:29:48 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
SEKÂ 1.12
High
SEKÂ 1.13
Low
SEKÂ 1.03
Mkt. cap
651.64M
Avg. vol.
2.05M
Volume
2.43M
52-wk high
SEKÂ 2.88
52-wk low
SEKÂ 0.34
EPS
-SEKÂ 0.27
Shares outstanding
624.18M
No. of employees
7
Open
SEKÂ 1.12
High
SEKÂ 1.13
Low
SEKÂ 1.03
Mkt. cap
651.64M
Avg. vol.
2.05M
Volume
2.43M
52-wk high
SEKÂ 2.88
52-wk low
SEKÂ 0.34
EPS
-SEKÂ 0.27
Shares outstanding
624.18M
No. of employees
7
News stories
From web sources and news partners
The Motley Fool
·
5 hours ago
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
10 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
19 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
JournalArta
·
8 minutes ago
S&P 500 Falls Into Correction as AI Spending Worries Grow
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB
CEOChristine Lind
Employees7
Founded1988
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemedivir.com